Get started
Bristol-Myers Squibb Co.Bristol-Myers Squibb Co.Bristol-Myers Squibb Co.

Bristol-Myers Squibb Co.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals Bonds

BMYMP chart


Full chart

Key stats


Market capitalization
‪120.99 B‬ USD
Dividend yield (indicated)
0.22%
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−4.43 USD
Net income (FY)
‪−8.95 B‬ USD
Revenue (FY)
‪48.30 B‬ USD
Shares float
‪2.03 B‬
Beta (1Y)
−0.76

Employees


Employees (FY)
‪34.1 K‬
Change (1Y)
0
Revenue / Employee (1Y)
‪1.42 M‬ USD
Net income / Employee (1Y)
‪−262.40 K‬ USD

About Bristol-Myers Squibb Company


Sector
Health Technology
CEO
Christopher S. Boerner
Headquarters
Princeton
Website
bms.com
Founded
1933
FIGI
BBG000002XP6
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BMYMP news



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

BMYMP highest yielding bonds


C
BMY4560589
Celgene Corporation 4.35% 15-NOV-2047
Yield to maturity
7.10%
Maturity date
Nov 15, 2047
US110122DS4
BRIST.MYERS 20/50
Yield to maturity
6.91%
Maturity date
Nov 13, 2050
C
BMY4036425
Celgene Corporation 5.25% 15-AUG-2043
Yield to maturity
6.40%
Maturity date
Aug 15, 2043
C
BMY4124214
Celgene Corporation 4.625% 15-MAY-2044
Yield to maturity
6.38%
Maturity date
May 15, 2044
US110122DR6
BRIST.MYERS 20/40
Yield to maturity
6.34%
Maturity date
Nov 13, 2040
US110122DX3
BRIST.MYERS 22/62
Yield to maturity
6.30%
Maturity date
Mar 15, 2062
C
BMY4275603
Celgene Corporation 5.0% 15-AUG-2045
Yield to maturity
6.24%
Maturity date
Aug 15, 2045
US110122DW5
BRIST.MYERS 22/52
Yield to maturity
6.22%
Maturity date
Mar 15, 2052
C
BMY4597874
Celgene Corporation 4.55% 20-FEB-2048
Yield to maturity
6.19%
Maturity date
Feb 20, 2048
BMY3883364
Bristol-Myers Squibb Company 3.25% 01-AUG-2042
Yield to maturity
6.10%
Maturity date
Aug 1, 2042
BMY.GC
Bristol-Myers Squibb Company 6.875% 01-AUG-2097
Yield to maturity
6.06%
Maturity date
Aug 1, 2097

See all BMYMP bonds 

Sparks


Curated watchlists where BMYMP is featured.

See all sparks 

Frequently Asked Questions


The current price of BMYMP is 900.55 USD — it has increased by 0.06% in the past 24 hours. Watch Bristol-Myers Squibb Co. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Bristol-Myers Squibb Co. stocks are traded under the ticker BMYMP.
BMYMP reached its all-time high on Nov 5, 2021 with the price of 2,000.00 USD, and its all-time low was 25.00 USD and was reached on Oct 4, 1974. View more price dynamics on BMYMP chart.
See other stocks reaching their highest and lowest prices.
BMYMP stock is 0.06% volatile and has beta coefficient of −0.76. Track Bristol-Myers Squibb Co. stock price on the chart and check out the list of the most volatile stocks — is Bristol-Myers Squibb Co. there?
Today Bristol-Myers Squibb Co. has the market capitalization of ‪120.99 B‬, it has decreased by −2.94% over the last week.
Yes, you can track Bristol-Myers Squibb Co. financials in yearly and quarterly reports right on TradingView.
BMYMP net income for the last quarter is ‪72.00 M‬ USD, while the quarter before that showed ‪1.21 B‬ USD of net income which accounts for −94.05% change. Track more Bristol-Myers Squibb Co. financial stats to get the full picture.
Yes, BMYMP dividends are paid quarterly. The last dividend per share was 0.50 USD. As of today, Dividend Yield (TTM)% is 4.06%. Tracking Bristol-Myers Squibb Co. dividends might help you take more informed decisions.
As of Mar 3, 2025, the company has ‪34.10 K‬ employees. See our rating of the largest employees — is Bristol-Myers Squibb Co. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Bristol-Myers Squibb Co. EBITDA is ‪18.49 B‬ USD, and current EBITDA margin is 39.98%. See more stats in Bristol-Myers Squibb Co. financial statements.
Like other stocks, BMYMP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bristol-Myers Squibb Co. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bristol-Myers Squibb Co. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bristol-Myers Squibb Co. stock shows the neutral signal. See more of Bristol-Myers Squibb Co. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.